ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.
作者信息
George James N
机构信息
The University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73190, USA.
出版信息
Curr Hematol Rep. 2005 May;4(3):167-9.
PMID:15865866
Abstract
摘要
相似文献
1
ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.ADAMTS13、血栓性血小板减少性紫癜和溶血性尿毒症综合征。
Curr Hematol Rep. 2005 May;4(3):167-9.
2
[TTP/HUS and VWF/ADAMTS-13].[血栓性血小板减少性紫癜/溶血尿毒综合征与血管性血友病因子/含凝血酶敏感蛋白基元的去整合素样金属蛋白酶13]
Rinsho Ketsueki. 2003 Dec;44(12):1144-53.
3
Thrombotic thrombocytopenic purpura.
Hematol J. 2004;5 Suppl 3:S6-11. doi: 10.1038/sj.thj.6200413.
4
Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?血栓性血小板减少性紫癜：终于有更简单的诊断方法了？
Thromb Haemost. 1999 Nov;82(5):1380-1.
5
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.血栓性血小板减少性紫癜和溶血尿毒综合征中的血管性血友病因子裂解蛋白酶
N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202.
6
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中血管性血友病因子裂解蛋白酶活性缺乏。
Expert Rev Cardiovasc Ther. 2003 Jul;1(2):243-55. doi: 10.1586/14779072.1.2.243.
7
[Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].[通过分析血管性血友病因子裂解蛋白酶激活进行血栓性血小板减少性紫癜/溶血尿毒综合征诊断的研究进展]
Nihon Naika Gakkai Zasshi. 2004 Mar 10;93(3):451-9. doi: 10.2169/naika.93.451.
8
Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.血小板活化与血小板凝块的形成：ADAMTS13缺乏导致血栓性血小板减少性紫癜。
Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):388-96. doi: 10.1161/01.ATV.0000058401.34021.D4. Epub 2003 Jan 30.
9
Recent advances in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的最新进展
Hematology Am Soc Hematol Educ Program. 2004:407-23. doi: 10.1182/asheducation-2004.1.407.
10
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.血栓性血小板减少性紫癜和溶血尿毒综合征中的血管性血友病因子裂解蛋白酶
N Engl J Med. 1999 Apr 29;340(17):1368; author reply 1369. doi: 10.1056/NEJM199904293401714.
引用本文的文献
1
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium.用于治疗多发性骨髓瘤的诱导策略对内皮细胞有有害影响。
Bone Marrow Transplant. 2020 Dec;55(12):2270-2278. doi: 10.1038/s41409-020-0947-9. Epub 2020 May 13.
Zotero 插件